Plantar Fasciitis Treatment Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type and, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Planter fasciitis is a common cause of foot pain caused by a repetitive strain injury. It affects the heel portion of the foot and results into tenderness of the sole. It is a type of muscle sole inflammation. It is prevalent among the people who stand on hard surface for long time. Foot stretches activities help individual to get relief from the pain of planter fasciitis. Planter fasciitis is caused when the strong band of tissue supports arch of foot become irritated and inflamed, this hurts the foot during walking. The global planter fasciitis treatment market is experiencing significant growth, and will grow considerably in the next few years. Orthotics is one of the commonly used product type of planter fasciitis, which is considered as the largest contributing product in the market growth. Orthotics are mostly prescribed by physicians for the treatment of planter fasciitis and provide various benefits including quick pain relief and low cost.

Planter fasciitis is common in individuals aged between 40 and 60 years, especially in women. The American Academy of Orthopedic Surgeons provides various guidelines on choosing the right foot wear, which helps to relieve plantar fasciitis.

COVID-19 Scenario Analysis: 

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. To prevent the spread of COVID-19, people are maintaining social distancing. Thus, they are avoiding to take the treatment of the planter fasciitis, which will directly impact on the market growth. The affect will resulted not only on the market growth but also on the patients suffering from planter fasciitis.     

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

According to the National center for health statistics (NCHS), globally 2 million people suffer from planter fasciitis every year. National Institute for Health and Care Excellence (NIHCE), reported that 80% cases suffering from heel pain and 10% of individuals will experience this problem during their lifetime. Due to the increasing number of advanced treatment related to planter fasciitis and rising number of obese individuals, North America dominates the overall market and it is considered as the largest contributor to the development of the planter fasciitis treatment market. In 2018, the U.S. FDA reduced the timeline period of clinical trial phase-IIb study of injectable Amino Fix for the treatment of planter fasciitis from two years to one year.  

The driving factor such as, availability of technologically advanced product, increasing the large number of treatment, inactive lifestyle of individual, rising geriatric population, rising prevalence of obesity, and rising adoption of orthotic treatment, drive the market growth of plantar fasciitis treatment market. Restraining factor such as, Increasing cost of raw material and declining high cost of product, lack of awareness about treatment, may hinder the growth of plantar fasciitis treatment market.

New product launches to flourish the market:

Manufacturers focus on producing new product with more improved capabilities that fuel the growth of plantar fasciitis treatment market and help individual to get relief from pain. In 2018, the U.S. FDA announced that they reduced the timeline period of clinical trial phase-IIb study of injectable Amino Fix for the treatment of planter fasciitis from two year to one year. For relieving foot pain, various industries manufacture types of orthotic device pain such as Ankle foot orthoses and knee-ankle foot orthoses, and it is the most effective method for those individuals who are suffering from the discomfort of planter fasciitis. In 2018, Revance Therapeutics, Inc. launched DaxibotulinumtoxinA for injection that is used to treat planter fasciitis. In 2017 Wiivv, launched custom-feet footwear, this product helps to relieve individual foot pain.  

Key benefits of the report:

• This study presents the analytical depiction of the global plantar fasciitis treatment market industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global plantar fasciitis treatment market share.
• The current market is quantitatively analyzed to highlight the global plantar fasciitis treatment market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
• The report provides a detailed global plantar fasciitis treatment market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the plantar fasciitis treatment Market research report:

• Which are the leading market players active in the plantar fasciitis treatment market?
• What current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the plantar fasciitis treatment market?
• What are the projections for the future that would help in taking further strategic steps?

  Plantar Fasciitis Treatment Market Report Highlights

Aspects	Details
By Type	Medication Therapy Orthotics Shockwave Therapy Surgery Others
By End User	Hospitals Ambulatory Surgical Center Clinics Others
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	GlaxoSmithKline Plc., Hanger Inc.,, KGaA (Otto bock Holding)., Otto bock SE & Co.,, Superfeet Worldwide, Inc.,, A. Algeo Ltd., Pfizer, Inc., Sanofi, Group (Dr. Scholl’s),, Bayer, Bauerfeid AG,